Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
2010/03/01 by Lawrence S. Kegeles, Anissa Abi-Dargham, Anissa Abi‐Dargham +9 · 567 citations
Medicine · Neuroscience · Psychology · #Dopamine #Dopamine receptor D2 #Dopaminergic #Internal medicine #Medicine #Neural and Behavioral Psychology Studies #Neuroscience #Neurotransmitter Receptor Influence on Behavior #Psychiatry #Psychology #Psychosis #Raclopride #Schizophrenia (object-oriented programming) #Schizophrenia research and treatment #Striatum #Ventral striatum
paper · doi:10.1001/archgenpsychiatry.2010.10
published in Archives of General Psychiatry 67(3), 231 (American Medical Association)
openalex publication_date 2010/03/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Abstract
CONTEXT: A long-standing version of the dopamine hypothesis of schizophrenia postulates that hyperactivity of dopaminergic transmission at D(2) receptors in the limbic striatum is associated with the illness and that blockade of mesolimbic D(2) receptors is responsible for the antipsychotic action of D(2) receptor antagonists. OBJECTIVE: To localize dopaminergic hyperactivity within the striatum in schizophrenia. DESIGN: Case-control study. SETTING: Inpatient research unit. PARTICIPANTS: Eighteen untreated patients with schizophrenia and 18 healthy control subjects matched for age, sex, ethnicity, parental socioeconomic status, cigarette smoking, and weight. MAIN OUTCOME MEASURES: Percentage change in dopamine D(2) receptor availability in striatal subregions within each subject measured by positron emission tomography with carbon 11-labeled raclopride before and during pharmacologically induced dopamine depletion. RESULTS: In the associative striatum, acute dopamine depletion resulted in a larger increase in D(2) receptor availability in patients with schizophrenia (mean [SD], 15% [7%]) than in control subjects (10% [7%], P = .045), suggesting higher synaptic dopamine concentration. Within the associative striatum, this effect was most pronounced in the precommissural dorsal caudate (15% [8%] in patients vs 9% [8%] in controls, P = .03). No between-group differences were observed in the limbic and sensorimotor striatum. CONCLUSIONS: These findings suggest that schizophrenia is associated with elevated dopamine function in associative regions of the striatum. Because the precommissural dorsal caudate processes information from the dorsolateral prefrontal cortex, this observation also suggests that elevated subcortical dopamine function might adversely affect performance of the dorsolateral prefrontal cortex in schizophrenia. On the other hand, the absence of a group difference in the limbic striatum brings into question the therapeutic relevance of the mesolimbic selectivity of second-generation antipsychotic drugs.
Citations
Cited by
- Integrative Brain Network and Salience Models of Psychopathology and Cognitive Dysfunction in Schizophrenia
- The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder
- An Integrative Perspective on the Role of Dopamine in Schizophrenia
- Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [18F]-VAT
- Dopamine’s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders
- Striosomes control dopamine via dual pathways paralleling canonical basal ganglia circuits
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
- Reward Processing in Mood Disorders and Schizophrenia: A Neurodevelopmental Framework
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
- Stress during critical periods of development and risk for schizophrenia
- Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
- Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- Glutamate and Psychosis Risk
- Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology
- Coordinated Specialty Care [wikipedia]
- Animal models of neuropsychiatric disorders. [europepmc]
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. [europepmc]
- Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. [europepmc]
- The nature of dopamine dysfunction in schizophrenia and what this means for treatment. [europepmc]
- Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography. [europepmc]
- Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. [europepmc]
- Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. [europepmc]
- Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. [europepmc]
- The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. [europepmc]
- Estimates of projection overlap and zones of convergence within frontal-striatal circuits. [europepmc]
- Glutamate and dopamine in schizophrenia: an update for the 21st century. [europepmc]
- Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. [europepmc]
- Schizophrenia and the eye. [europepmc]
- Pathway-Specific Dopamine Abnormalities in Schizophrenia. [europepmc]
- An Integrative Perspective on the Role of Dopamine in Schizophrenia. [europepmc]
- The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia. [europepmc]
- A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia. [europepmc]
- Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis. [europepmc]
- Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. [europepmc]
- A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine. [europepmc]
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms. [europepmc]
- Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. [europepmc]
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. [europepmc]
- Neuroimaging Biomarkers in Schizophrenia. [europepmc]
- The effects of social isolation stress and discrimination on mental health. [europepmc]
Related